J Pers Med. 2017 Jun 28;7(3). pii: E5. doi: 10.3390/jpm7030005.
The Clinical and Economic Impact of Inaccurate EGFR Mutation Tests in the Treatment of Metastatic Non-Small Cell Lung Cancer.
companion diagnostic test; epidermal growth factor receptor (EGFR); health care costs; in vitro diagnostic (IVD); molecular diagnostic assay; non-small cell lung cancer (NSCLC)
Free full text